We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates

By HospiMedica International staff writers
Posted on 26 Nov 2024

Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a heart attack or stroke. More...

Clinicians at Intermountain Health (Salt Lake City, UT, USA) regularly analyze patient data through their electronic health system to identify individuals who may have heart disease without knowing it. The Intermountain Risk Score (IMRS) is a well-established, sex-specific tool that predicts the risk of major cardiovascular events and death, using factors such as age and results from complete blood count and basic metabolic profile testing. These scores are automatically calculated based on data entered into the electronic health records. If a patient's score is high, their care team is alerted. In a significant new study, the researchers discovered that the IMRS could also predict whether patients being assessed for kidney transplant would experience a major cardiac event, such as a heart attack or stroke.

The study focused on evaluating the IMRS's accuracy in predicting cardiac events in patients considered for kidney transplant. The researchers identified 891 patients who were assessed for transplant surgery at Intermountain Health between June 2015 and April 2024. Of these, 200 patients lacked the necessary laboratory tests to calculate an IMRS, so they were excluded from further analysis. This left 691 patients with sufficient data to calculate their IMRS. The average age of these patients was 55.9 years, and 34.3% were women. Over a five-year follow-up period, 171 of the 691 patients experienced a major cardiac event.

The researchers found that the IMRS was effective in predicting these outcomes, highlighting the potential of using such a score in patients being evaluated for kidney transplant. However, approximately 200 individuals in the study were excluded due to insufficient laboratory data. The next steps involve validating the risk score in another patient population, exploring whether adding routinely collected kidney patient data to the score improves its predictive ability, and conducting a prospective clinical trial to determine if using the score to guide clinical care improves patient outcomes.

“This study demonstrates that we could adapt our already existing risk score guide to help identify which of these patients might also be at risk for having a heart event, which could lead to better and more personalized treatment,” said Benjamin Horne, PhD, director of cardiovascular and genetic epidemiology at the Intermountain Health.

Related Links:
Intermountain Health


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Pediatric Cast Saw
CSP-201 Quietcast
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.